Persistent PSA After Radical Prostatectomy: A Marker of Mortality Risk?
A large cohort study published in JAMA Oncology examines the implications of persistent prostate-specific antigen (PSA) levels after radical prostatectomy (RP), raising important questions about monitoring duration and treatment timing in prostate cancer. 🎯 Objective To determine if persistent PSA levels post-RP predict increased mortality risk, an
